PREFIJECT-M is a product indicated as a viscoelastic supplement or a replacement for synovial fluid in the knee joint. It contains two high-purity cross-linked biopolymers, 36 mg sodium hyaluronate, 67.5 mg chondroitin sodium sulphate and 67.5 mg N-acetylglucosamine in a 2.25 ml pre-filled syringe. PREFIJECT-M is the first and only triple combination in the Greek market.
The unique blend of Prefiject-M acts synergistically by inhibiting the destruction processes, stimulating the anabolic processes involved in the formation of new cartilage and maintaining the rheological homeostasis of the joint. The combination of the 3 ingredients allows the focused triple topical action while facilitating the causal and symptomatic treatment of osteoarthritis.
Prefiject – M is administered with a single infusion. The duration of its beneficial effect ranges from a few months to a year depending on the patient’s condition and age, the patient’s lifestyle, the severity of the condition and the type of affected joints.
The combination of the 3 ingredients is specially adopted for severe osteoarthritis, offering:
- Prolonged pain relief
- Improved mobility and reduced mechanical strain on the joint
- Cartilage protection
- Excellent tolerance
